| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 113 |
| 1 | AZATHIOPRINE | 18 |
| 2 | INFLIXIMAB | 17 |
| 3 | APREPITANT | 12 |
| 4 | ERGOCALCIFEROL | 12 |
| 5 | BEVACIZUMAB | 11 |
| 6 | GEMCITABINE HYDROCHLORIDE | 11 |
| 7 | PREDNISONE | 11 |
| 8 | CARBOPLATIN | 10 |
| 9 | GEMCITABINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APREPITANT | 12 | 0.0016 |
| 1 | PINDOLOL | 1 | 0.0012 |
| 2 | ETHIODIZED OIL | 1 | 0.0008 |
| 3 | ZIPRASIDONE | 2 | 0.0006 |
| 4 | VANDETANIB | 1 | 0.0006 |
| 5 | ECALLANTIDE | 1 | 0.0005 |
| 6 | ERGOCALCIFEROL | 12 | 0.0004 |
| 7 | DEFLAZACORT | 1 | 0.0004 |
| 8 | RIFABUTIN | 1 | 0.0004 |
| 9 | GEMCITABINE HYDROCHLORIDE | 11 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 23 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 2 | Purine Antimetabolite [EPC] | 18 |
| 3 | Vitamin C [EPC] | 14 |
| 4 | Provitamin D2 Compound [EPC] | 12 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 |
| 6 | Proton Pump Inhibitor [EPC] | 11 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 |
| 8 | Vitamin B12 [EPC] | 11 |
| 9 | Platinum-based Drug [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 3 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 4 | Purine Antimetabolite [EPC] | 18 | 0.0002 |
| 5 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 6 | Integrin Receptor Antagonist [EPC] | 9 | 0.0001 |
| 7 | Folate Analog [EPC] | 4 | 0.0001 |
| 8 | Vitamin A [EPC] | 4 | 0.0001 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |